<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Accuray Incorporated — News on 6ix</title>
<link>https://6ix.com/company/accuray-incorporated</link>
<description>Latest news and press releases for Accuray Incorporated on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/accuray-incorporated" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835478078dffbe2df0e36d9.webp</url>
<title>Accuray Incorporated</title>
<link>https://6ix.com/company/accuray-incorporated</link>
</image>
<item>
<title>Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026</guid>
<pubDate>Wed, 22 Apr 2026 20:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.</description>
</item>
<item>
<title>Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-appoints-paul-miele-as-senior-vice-president-and-chief-commercial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-appoints-paul-miele-as-senior-vice-president-and-chief-commercial-officer</guid>
<pubDate>Mon, 06 Apr 2026 04:00:00 GMT</pubDate>
<description>MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today</description>
</item>
<item>
<title>Accuray Reports Fiscal 2026 Second Quarter Financial Results</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2026-second-210500999</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2026-second-210500999</guid>
<pubDate>Wed, 04 Feb 2026 21:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025.</description>
</item>
<item>
<title>Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-report-second-quarter-fiscal-210500292</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-report-second-quarter-fiscal-210500292</guid>
<pubDate>Wed, 21 Jan 2026 21:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on February 4, 2026.</description>
</item>
<item>
<title>Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-announces-first-phase-comprehensive-220000083</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-announces-first-phase-comprehensive-220000083</guid>
<pubDate>Mon, 15 Dec 2025 22:00:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today announced the first phase of its comprehensive strategic, operational, and organizational transformation plan. This phase is designed to realign its organization to produce sharper accountability, tighter cost control, and faster execution. The plan also right-sizes Accuray's cost structure, outsources selected non-core activities while building internal global centers of excellence, reallocates engineering resources, and better positions the commercial</description>
</item>
<item>
<title>Accuray Reports Fiscal 2026 First Quarter Financial Results</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2026-first-210500831</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2026-first-210500831</guid>
<pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025.</description>
</item>
<item>
<title>Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-incorporated-reports-inducement-award-200300900</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-incorporated-reports-inducement-award-200300900</guid>
<pubDate>Fri, 31 Oct 2025 20:03:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer. As a material inducement to Mr. La Neve joining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), the Board of Directors of the company approved granting Mr. La Neve awards consisting of (i)1,500,000 restricted stock units covering shares of the company's common stock and (ii) 1,500,000 performance-based</description>
</item>
<item>
<title>Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-report-first-quarter-fiscal-113500782</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-report-first-quarter-fiscal-113500782</guid>
<pubDate>Tue, 28 Oct 2025 11:35:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025.</description>
</item>
<item>
<title>Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-accelerates-transformation-efforts-appointment-132000829</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-accelerates-transformation-efforts-appointment-132000829</guid>
<pubDate>Mon, 20 Oct 2025 13:20:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today announced it is engaging in a significant organizational, strategic, and operational transformation. To accelerate this work, the company's Board of Directors has appointed proven industry leaders with deep operational expertise to drive execution, strengthen performance, and enhance competitiveness. The transformation plan initiatives, most of which will be implemented during the current fiscal year, are designed to increase operating margins, enhance o</description>
</item>
<item>
<title>Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-announces-milestone-cancer-patients-113500878</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-announces-milestone-cancer-patients-113500878</guid>
<pubDate>Wed, 08 Oct 2025 11:35:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today that 5D Clinics has treated the first patients in the city of Melbourne, Australia, using the CyberKnife S7™ System. 5D Clinics and joint venture partner Icon Group will open and operate CyberKnife System centers across Australia*, with the goal of making it easier for cancer patients to obtain state-of-the-art precision robotic stereotactic body radiation therapy (SBRT) and stereotactic radio surgery (SRS) treatments closer to home. With an in</description>
</item>
<item>
<title>Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-university-wisconsin-madison-announce-113500436</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-university-wisconsin-madison-announce-113500436</guid>
<pubDate>Tue, 30 Sep 2025 11:35:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatment delivery platform. As part of the MOU, the two parties outlined their intent to collaborate on clinical research, education and training, and adaptive technology development, to help empower medical care teams to raise the bar i</description>
</item>
<item>
<title>Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-launches-one-radiotherapy-solution-113500866</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-launches-one-radiotherapy-solution-113500866</guid>
<pubDate>Fri, 26 Sep 2025 11:35:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adaptive radiotherapy with the introduction of the Accuray Stellar™* Solution. Initially for the U.S. market, the new Accuray technology is not just a system, it's a solution, comprised of a comprehensive tool set designed to empower clinical teams to address the evolving treatment needs of patients undergoing radiotherapy.</description>
</item>
<item>
<title>Accuray to Host Analyst Event at the American Society of Radiation Oncology Meeting on September 29, 2025</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-host-analyst-event-american-201000500</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-host-analyst-event-american-201000500</guid>
<pubDate>Thu, 11 Sep 2025 20:10:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29, 2025, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT (4:30 pm ET).</description>
</item>
<item>
<title>Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-reports-fourth-quarter-fiscal-200500373</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-reports-fourth-quarter-fiscal-200500373</guid>
<pubDate>Wed, 13 Aug 2025 20:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2025, ended June 30, 2025.</description>
</item>
<item>
<title>Accuray to Report Fourth Quarter Fiscal 2025 Financial Results on August 13, 2025</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-report-fourth-quarter-fiscal-200500719</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-report-fourth-quarter-fiscal-200500719</guid>
<pubDate>Wed, 30 Jul 2025 20:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2025, ended June 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on August 13, 2025.</description>
</item>
<item>
<title>Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-announces-convertible-notes-exchange-113000326</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-announces-convertible-notes-exchange-113000326</guid>
<pubDate>Fri, 06 Jun 2025 11:30:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2026 (the "Notes") to exchange an aggregate of $82.0 million principal amount of Notes for an aggregate of 8,881,579 shares of the Accuray's common stock (the "Shares"). As part of the exchange consi</description>
</item>
<item>
<title>Accuray to Participate in the Jefferies Global Healthcare Conference 2025</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-participate-jefferies-global-healthcare-233000985</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-participate-jefferies-global-healthcare-233000985</guid>
<pubDate>Thu, 29 May 2025 23:30:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025. The management team is scheduled to participate in a fireside chat on Wednesday, June 4th, 2025, at 5:30pm EDT/2:30pm PDT.</description>
</item>
<item>
<title>Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-showcases-long-term-data-113500364</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-showcases-long-term-data-113500364</guid>
<pubDate>Wed, 07 May 2025 11:35:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife® System in the treatment of prostate cancer at multiple stages of the cancer journey. The studies, shared at the annual congress held in Vienna, Austria, indicate the system's accuracy and precision enable treatment of high-risk disease, as well as recurrent prostate cancer following prostatectomy, wi</description>
</item>
<item>
<title>Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-announces-first-srs-sbrt-201000234</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-announces-first-srs-sbrt-201000234</guid>
<pubDate>Mon, 05 May 2025 20:10:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) announced today that the CyberKnife® Center Salzburg is the first in Austria to treat patients with the CyberKnife® System, expanding access to stereotactic radiosurgery (SRS) and ultra-hypofractionated stereotactic body radiation therapy (SBRT), treatment processes necessitating an extremely high degree of precision and accuracy. The CyberKnife Center Salzburg's team used the Accuray CyberComm™ technology to commission their system, the latest-generation Cybe</description>
</item>
<item>
<title>Accuray Reports Fiscal 2025 Third Quarter Financial Results</title>
<link>https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2025-third-200500491</link>
<guid isPermaLink="true">https://6ix.com/company/accuray-incorporated/news/accuray-reports-fiscal-2025-third-200500491</guid>
<pubDate>Wed, 30 Apr 2025 20:05:00 GMT</pubDate>
<description>Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025.</description>
</item>
</channel>
</rss>